Recombinant Mouse Anti-fHbp Antibody (JAR41) (CAT#: HPAB-0023-WJ)

This product is a mouse monoclonal IgG1 antibody targeting the N-terminal domain of Neisseria meningitidis factor H binding protein (fHbp) variants. This antibody is generated from a human factor H (fH) transgenic BALB/c mouse immunized with a recombinant fHbp ID 1. This antibody is bactericidal when tested in combination with a second non-bactericidal anti-fHbp mAb


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
ELISA

Figure 1 Binding of anti-FHbp MAbs to FHbp ID 22 by ELISA.

Figure 1 Binding of anti-FHbp MAbs to FHbp ID 22 by ELISA.

(B) Binding of MAb JAR 41, which recognizes an epitope in the N-terminal domain of FHbp.

Konar, M., Pajon, R., & Beernink, P. T. (2015). A meningococcal vaccine antigen engineered to increase thermal stability and stabilize protective epitopes. Proceedings of the National Academy of Sciences, 112(48), 14823-14828.

FC

Figure 2 Binding of mAbs to live N. meningitidis strains as measured by flow cytometry.

Figure 2 Binding of mAbs to live N. meningitidis strains as measured by flow cytometry.

Panel f, thick black line, 50 µg/ml of JAR 41 with wild-type strain M1239 with fHbp in variant group 3; dark shaded area, 5 µg/ml of JAR 41 (lower concentrations of JAR 41 were not tested); blue line, 50 µg/ml of JAR 5 (specific for fHbp variant group 1); Light gray shade area, 50 µg/ml of JAR 41 incubated with M1239 fHbp knock-out mutant.

Vu, D. M., Pajon, R., Reason, D. C., & Granoff, D. M. (2012). A broadly cross-reactive monoclonal antibody against an epitope on the N-terminus of meningococcal fHbp. Scientific reports, 2, 341.


Specifications

  • Immunogen
  • Recombinant fHbp ID 1 (variant group 1)
  • Host Species
  • Mouse
  • Derivation
  • Hybridoma
  • Type
  • Mouse IgG1
  • Specificity
  • N. meningitidis fHbp
  • Species Reactivity
  • N. meningitidis
  • Clone
  • JAR41
  • Applications
  • ELISA, FC, DB, Inhib
  • Related Disease
  • Neisseria meningitidis infection

Applications

  • Application Notes
  • The fHbp antibody has been reported in applications of Enzyme-linked Immunosorbent Assay, Western Blot, Flow Cytometry.
    For ELISA: Binding of human FH and anti-FHbp MAbs to purified FHbp was performed as described. Briefly the wells of a microtiter plate were coated with 2 µg/mL of purified recombinant FHbp in PBS. After blocking with PBS containing 0.01% (wt/vol) sodium azide and 1% (wt/vol) BSA, serial dilutions of purified human FH, anti-FHbp MAbs, or a control Penta-His MAb were added and incubated at room temperature for 1 h. Bound FH was detected with sheep anti-FH (1:7,000) and donkey anti-sheep IgG conjugated to alkaline phosphatase (1:5,000). Bound MAbs were detected with goat anti-mouse IgG conjugated to alkaline phosphatase (1:5,000). The ELISAs were developed using paranitrophenyl phosphate substrate (1 mg/mL), and the optical density at 405 nm (OD405 nm) was measured after 30 min at room temperature. Relative binding was calculated as the ratio in the concentration of FH or MAb needed to obtain an OD405 nm of 2.0 for WT versus mutant FHbp. FH and mAb binding was tested in at least three experiments, and the means and 2 SE are shown from two experiments, each performed in triplicate.
    For FC: Binding of the murine mAbs to the surface of live encapsulated bacteria was measured by flow cytometry, which was performed as described previously. The group B test strains were H44/76 (B:15:P1.7,16; ST-32) with fHbp ID 1; a previously described isogenic mutant, which had been engineered to have decreased expression of fHbp ID 1; 8047 (B:2b:P1.5-1, 2-2; ST-8), which expressed fHbp ID 77 in variant group 2; and M1239 (B:14:P1.23,14; ST-41/44), which expressed fHbp ID 28 in variant group 3. The bacterial cells were grown in Mueller Hinton broth culture, harvested by centrifugation, washed, and resuspended in buffer as described elsewhere.

Target

  • Alternative Names
  • FHbp; Fa; Factor H binding protein

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone JAR41"

See other products for "fHbp"

Blocking Antibody

CAT Product Name Application Type
NEUT-841CQ Recombinant Mouse Anti-fhbP Antibody (JAR5) ELISA, WB, BL IgG2b, κ

Recombinant Antibody

CAT Product Name Application Type
FAMAB-0136CQ Recombinant Human Anti-fHbp Antibody (chJAR 1) ELISA, FC, Inhib Chimeric (mouse/human) IgG1
FAMAB-0137CQ Recombinant Human Anti-fHbp Antibody (chJAR 3) ELISA, WB, BL, FC Chimeric (mouse/human) IgG1
FAMAB-0138CQ Recombinant Human Anti-fHbp Antibody (chJAR 5) ELISA, WB, BL, FC Chimeric (mouse/human) IgG1
FAMAB-0139CQ Recombinant Mouse Anti-fHbp Antibody (JAR 1) ELISA, FC, WB, Inhib Mouse IgG3
FAMAB-0140CQ Recombinant Mouse Anti-fHbp Antibody (JAR 3) ELISA, WB, Block, FC Mouse IgG3

Fab Fragment Antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for HPAB-0023-WJ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare